Twenty-nine patients with acute destructive pancreatitis received combined therapy including recombinant interleukin-2 (ronkoleukin). Treatment with this interleukin led to a decrease of hypercytokinemia, reduced rate of purulent -- septic complications and surgical operations because of these complications.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!